EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Gut Microbiota as a Potential Modulator of Response to Biologic and Small-Molecule Therapies in Inflammatory Bowel Disease

Kacper Margul, Agnieszka Krawczyk iD

International Journal of Molecular Sciences · 03.11.2026 · 27 (21) · 9836

DOI: 10.3390/ijms27219836 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 03.11.2026. Verfasst von Kacper Margul und 1 weiteren Autor:innen. Beteiligte Einrichtung: Students' Scientific Group of Microbiology, Faculty of Medicine, Jagiellonian University Medical College, 31-121 Krakow, Poland. Hauptthemen laut MEDLINE: Inflammatory Bowel Diseases, Gastrointestinal Microbiome. Die Arbeit nennt 103 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Science Centre.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The therapeutic landscape of inflammatory bowel disease (IBD) has expanded substantially with the development of biologic and small-molecule therapies. Nevertheless, many patients fail to respond to these treatments or experience a secondary loss of response. The mechanisms underlying treatment failure remain incompletely understood. Given the ability of gut microorganisms to modify therapeutic compounds, sustain pro-inflammatory immune activation, alter intestinal barrier function and produce bioactive metabolites, the gut microbiota may represent an important modulator of therapeutic response. To summarize current evidence on the role of the gut microbiota in response to biologic and small-molecule therapies in IBD, with particular emphasis on potential mechanisms of drug–microbiota interactions and their implications for treatment response and non-response. Accumulating evidence suggests that the gut microbiota may influence therapeutic efficacy through direct modification of drugs and indirect effects mediated by host immunity, intestinal barrier function and microbial metabolites. Microbial signatures associated with response to individual biologic therapies have been identified, although findings remain heterogeneous. Emerging evidence also indicates that non-bacterial components of the gut ecosystem may contribute to treatment response. The gut microbiota represents a biologically plausible modulator of therapeutic response in IBD. Integration of microbiome data with host genetic and immunological features may help identify biomarkers capable of predicting response to individual therapeutic agents.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Inflammatory Bowel DiseasesGastrointestinal MicrobiomeHumansAnimalsIntestinal Barrier Function

Stichwörter der Autor:innen

biologic therapiesdrug–microbiota interactionsgut microbiotainflammatory bowel diseasesmall-molecule therapiestherapeutic response

Autor:innen und Institutionen

  • Students' Scientific Group of Microbiology, Faculty of Medicine, Jagiellonian University Medical College, 31-121 Krakow, Poland.
  • Department of Molecular Medical Microbiology, Chair of Microbiology, Faculty of Medicine, Jagiellonian University Medical College, 31-121 Krakow, Poland.

ORCID-Profile: Agnieszka Krawczyk

Förderung

  • National Science Centre

Zitieren

APA

Margul, K., & Krawczyk, A. (2026). Gut Microbiota as a Potential Modulator of Response to Biologic and Small-Molecule Therapies in Inflammatory Bowel Disease. International Journal of Molecular Sciences, 27(21), 9836. https://doi.org/10.3390/ijms27219836

Vancouver

Margul K, Krawczyk A. Gut Microbiota as a Potential Modulator of Response to Biologic and Small-Molecule Therapies in Inflammatory Bowel Disease. International Journal of Molecular Sciences. 2026;27(21):9836. doi:10.3390/ijms27219836

BibTeX
@article{Margul2026,
  author = {Margul, Kacper and Krawczyk, Agnieszka},
  title = {Gut Microbiota as a Potential Modulator of Response to Biologic and Small-Molecule Therapies in Inflammatory Bowel Disease},
  journal = {International Journal of Molecular Sciences},
  year = {2026},
  volume = {27},
  number = {21},
  pages = {9836},
  doi = {10.3390/ijms27219836}
}
Kostenlos starten →